Under construction – not a live service
Sign in
Taking people in United StatesNo phase

A relationships and sexual health program for autistic adults

Tests a group teaching program with coaching in autistic adults.

Plain-language title generated from the registry record
Registry title: Piloting the Competence in Romance and Understanding Sexual Health Curriculum

Key facts

Where
Brookline, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 30 years old?

Source: NCT07406100, who can take part

Where in United States

  • Boston Children's Hospital, Two Brookline PlaceBrookline, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Boston Children's Hospital
Trial code
NCT07406100
Record updated
24 April 2026
Original description
The goal of this clinical trial is to learn whether the CRUSH curriculum is possible (feasible), whether it fits the needs of the adults it is designed for (acceptable), and shows initial signs of being helpful (efficacious). CRUSH is a group-based behavioral intervention plus 1-1 coaching designed to provide sexual education and improve the skills of autistic adults for intimate relationships.Read full original descriptionShow less

A Pilot Investigation of the Competence in Romance and Understanding Sexual Health Curriculum

The goal of this clinical trial is to learn whether the CRUSH curriculum is possible (feasible), whether it fits the needs of the adults it is designed for (acceptable), and shows initial signs of being helpful (efficacious). CRUSH is a group-based behavioral intervention plus 1-1 coaching designed to provide sexual education and improve the skills of autistic adults for intimate relationships.

The main goals of the project are to:

* Evaluate the feasibility and acceptability of the CRUSH curriculum in the context of a clinical trial with a waitlist control condition. * Initial exploration of how the CRUSH curriculum works and whether it is helpful.

Participants will complete:

* A screening call. * Confirmation of clinical characteristics (autism features, language ability, cognitive ability). * 3 visits to assess knowledge and behaviors related to dating and sexual health at each point throughout the training curriculum (before beginning, midway, and after finishing). * 20 sessions of the CRUSH curriculum plus 1-1 coaching sessions. After each session, provide feedback about the session.

Inclusion: 18;0 to 30;11 years old; Either documentation of a prior diagnosis of autism spectrum disorder or receipt of services based on an autism spectrum diagnosis OR self identification as being autistic / on the autism spectrum and meeting the clinical cut-off on either the Autism Diagnostic Observation Schedule or the Autism Spectrum Quotient; Ability to provide consent for the protocol and understand task demands. The Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-2) may be used to confirm cognitive level. In prior work, adults with full scale IQ of 70 or above on the WASI-2 typically meet this criterion, but a licensed clinician will review individuals who fall below an IQ of 70 on an individual basis to determine eligibility; Fluent in English.

Exclusion: Major mental illness (e.g., bipolar disorder, schizophrenia, or psychosis); Medical conditions that impact sexual function (e.g., pituitary tumor); Significant sensory, motor, or physical conditions that would prevent valid participation in assessments or intervention; Non-English-speaking participants (less than 50% of speech in English); Known genetic etiology of ASD (e.g., Fragile X); Live more than 50 miles from the site in Brookline, MA where intervention and assessment sessions will be offered; Receipt of other sexual health/dating curricula as an adult.

ClinicalTrials.gov NCT07406100